A detailed history of Ramirez Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Ramirez Asset Management, Inc. holds 13,934 shares of ABBV stock, worth $2.39 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
13,934
Previous 13,734 1.46%
Holding current value
$2.39 Million
Previous $2.36 Billion 16.81%
% of portfolio
0.53%
Previous 0.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $32,768 - $39,866
200 Added 1.46%
13,934 $2.75 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $265,000 - $309,461
1,712 Added 14.24%
13,734 $2.36 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.19 Million - $1.35 Million
7,436 Added 162.15%
12,022 $2.19 Billion
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $612,643 - $709,224
4,586 New
4,586 $684 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ramirez Asset Management, Inc. Portfolio

Follow Ramirez Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramirez Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ramirez Asset Management, Inc. with notifications on news.